$60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Job training; federal education funding."
You can find more data on corporate lobbying on Quiver Quantitative.
UTI Insider Trading Activity
UTI insiders have traded $UTI stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, LLC COLISEUM has made 0 purchases and 4 sales selling 4,134,369 shares for an estimated $126,304,273.
- SHERRELL SMITH (EVP, Chief Academic Officer) has made 0 purchases and 10 sales selling 106,773 shares for an estimated $2,910,733.
- JEROME ALAN GRANT (Chief Executive Officer) sold 56,492 shares for an estimated $1,909,429
- CHRISTOPHER E. KEVANE (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 29,400 shares for an estimated $1,003,260.
- TODD A HITCHCOCK (EVP/COO) has made 0 purchases and 2 sales selling 27,500 shares for an estimated $917,470.
- GEORGE W. BROCHICK has made 0 purchases and 2 sales selling 14,000 shares for an estimated $411,799.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UTI Hedge Fund Activity
We have seen 125 institutional investors add shares of UTI stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 2,248,338 shares (+inf%) to their portfolio in Q1 2025, for an estimated $57,737,319
- CONGRESS ASSET MANAGEMENT CO added 1,866,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $63,265,140
- COLISEUM CAPITAL MANAGEMENT, LLC removed 1,704,881 shares (-24.9%) from their portfolio in Q1 2025, for an estimated $43,781,344
- DUMAC, INC. removed 1,681,681 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,185,568
- LORD, ABBETT & CO. LLC added 1,077,076 shares (+58.3%) to their portfolio in Q1 2025, for an estimated $27,659,311
- HOOD RIVER CAPITAL MANAGEMENT LLC added 1,021,592 shares (+inf%) to their portfolio in Q1 2025, for an estimated $26,234,482
- DRIEHAUS CAPITAL MANAGEMENT LLC added 803,402 shares (+inf%) to their portfolio in Q1 2025, for an estimated $20,631,363
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UTI Analyst Ratings
Wall Street analysts have issued reports on $UTI in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 06/12/2025
- Truist Securities issued a "Buy" rating on 05/22/2025
- Lake Street issued a "Buy" rating on 05/21/2025
- Rosenblatt issued a "Buy" rating on 05/08/2025
- Northland Capital Markets issued a "Outperform" rating on 02/06/2025
To track analyst ratings and price targets for UTI, check out Quiver Quantitative's $UTI forecast page.
UTI Price Targets
Multiple analysts have issued price targets for $UTI recently. We have seen 5 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Alexander Paris from Barrington Research set a target price of $36.0 on 06/12/2025
- Jasper Bibb from Truist Securities set a target price of $40.0 on 05/22/2025
- Eric Martinuzzi from Lake Street set a target price of $38.0 on 05/21/2025
- Steve Frankel from Rosenblatt set a target price of $36.0 on 05/08/2025
- Mike Grondahl from Northland Capital Markets set a target price of $34.0 on 02/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
